Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Eli Lilly

Midday stock movers: Alphabet, Super Micro, Eli Lilly and more

Here are the stocks making the biggest market moves.

The Street

Dow Falls As Super Micro Crashes; Meta Dives As Microsoft Gains After Results (Live Coverage)

Dow Jones stocks fell after economic data in the stock market today. Nvidia rival Advanced Micro Devices fell while a Warren Buffett stock dived after earnings.

Investors Business Daily

Dow Jones Falls After Jobs Data, GDP Report; Super Micro Plunges 30%

Stock Market Today: The Dow Jones fell Wednesday after jobs data and GDP. Google stock surged on earnings.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Eli Lilly stock crushed as weight loss sales, profits, disappoint Wall Street

Eli Lilly's weight loss treatments have powered the company into the top ten list of megacap U.S. stocks.

The Street

Eli Lilly Plummets On Rare — But 'Big' — Sales Miss For Diabetes, Weight-Loss Drugs

Eli Lilly stock crashed Wednesday after the pharma giant cut its 2024 outlook following a "big" miss for its diabetes and weight-loss drugs.

Investors Business Daily

Stock Market Today: Stocks close lower as Treasury yields climb

Another move higher in Treasury bond yields kept Wall Street in the red, with big jobs and earnings ahead as traders close out a challenging October.

The Street

Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap

December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.28% this morning as strong quarterly results from Alphabet boosted sentiment, while investors also awaited a fresh batch of U.S. economic data and earnings reports from “Magnificent Seven” companies Microsoft and Meta.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Futures Fall, Techs Rise; Google, Reddit Jump But Caterpillar, Eli Lilly, AMD Tumble

The Nasdaq hit a new high in Tuesday's mixed session. Google and Reddit jumped on earnings late. AI second fiddle AMD tumbled.

Investors Business Daily

Will New CFO Offer Annual Guidance For Google Stock?

When Alphabet reports Q3 earnings, Wall Street analysts will look for its new Chief Financial Officer, Anat Ashkenazi, to set her priorities.

Investors Business Daily

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals industry behind them

Evening Standard

Stock Market Today: Nasdaq Holds Gains As Tesla Soars; A New Buy Point Shows In ServiceNow (Live Coverage)

The stock market today showed a mostly bullish streak in early trading Thursday amid a fall in weekly jobless claims and a torrent of earnings news.

Investors Business Daily

Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet

Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's experimental triple.

Investors Business Daily

3 Top Healthcare Stocks to Buy for Growth and Dividends

Investors seeking growth and dividend income in the healthcare sector may want to consider Eli Lilly, Gilead Sciences, and Amgen, which have delivered impressive returns and boast strong pipelines and strategic moves.

Barchart

Eli Lilly Sues Over Knock-Off Weight-Loss Drugs

Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their drug, Zepbound.

International Business Times

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval?

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

The Independent UK

UK regulator approves second Alzheimer's drug in months but government won't pay for it

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to taxpayers

The Independent UK

New Alzheimer’s drug rejected for NHS use – because it’s not worth the money

Alzheimer’ patients in UK left behind over regulator’s decision to reject use of new drugs

StockNews.com

3 Healthcare Stocks That Can Thrive in Any Economy

The healthcare market shows promise due to heightened demand for quality care, technological advancements, preventive measures, and increased public investment, ensuring resilience in any economic condition. Therefore, investors could now consider top healthcare stocks, such as Eli Lilly (LLY), Merck & Co. (MRK), and Abbott Laboratories (ABT). Keep reading.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Nvidia's 84% Expected Profit Growth Looms Large In S&P 500

Nvidia is expected to boost the S&P 500 Q3 earnings growth rate. Meta Platforms and Alphabet may lift Communications Services earnings.

Investors Business Daily

Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug

Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide.

Fortune

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

'Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff Sonnenfeld and Steven Tian.

The Conversation

Buyer beware: Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease.

Investors Business Daily

8 Stocks Poised To Report Nvidia-Beating Profit Growth Any Day Now

S&P 500 earnings season is kicking off. And some companies are expected to put up some huge numbers — even bigger than Nvidia

Investors Business Daily

Dow Jones Futures: Stock Market Rebounds As Nvidia, Robinhood Lead 11 Buys; AI Giant's Sales Strong

The Nasdaq led Tuesday's market rebound. Nvidia powered past another buy point, with many other stocks actionable. AI giant Taiwan Semi reported strong sales.

The Conversation

Mounjaro will soon be available as a weight loss treatment on the NHS – here’s what that means for patients

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice). Previously, it was only available on the NHS for patients with diabetes.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations